We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.6B
AUM Growth
-$57.7M
Cap. Flow
-$90.7M
Cap. Flow %
-5.69%
Top 10 Hldgs %
17.06%
Holding
1,655
New
414
Increased
301
Reduced
390
Closed
477

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$10.1M
2
CEG icon
Constellation Energy
CEG
+$9.73M
3
AMZN icon
Amazon
AMZN
+$8.28M
4
SMAR
Smartsheet Inc.
SMAR
+$7.44M
5
NVDA icon
NVIDIA
NVDA
+$5.46M

Sector Composition

Rank Sector Weight
1 Technology 14.63%
2 Consumer Discretionary 10.41%
3 Healthcare 8.03%
4 Communication Services 6.75%
5 Financials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBI
1101
Trueblue
TBI
$315M
$88.2K 0.01%
+10,500
New +$81.1K
TWI icon
1102
Titan International
TWI
$465M
$87.6K 0.01%
12,900
-1,774
-12% -$12.8K
SRTS icon
1103
Sensus Healthcare
SRTS
$51.7M
$87.1K 0.01%
12,586
+1,808
+17% +$13.2K
CXDO icon
1104
Crexendo
CXDO
$214M
$87K 0.01%
16,643
-1,558
-9% -$8.24K
CIFR icon
1105
Cipher Digital
CIFR
$6.77B
$86K 0.01%
+18,543
New +$105K
LUMN icon
1106
Lumen
LUMN
$6.7B
$85.9K 0.01%
+16,180
New +$112K
LTRX icon
1107
Lantronix
LTRX
$260M
$85.1K 0.01%
20,666
-2,200
-10% -$7.86K
AMRX icon
1108
Amneal Pharmaceuticals
AMRX
$5.73B
$85.1K 0.01%
+10,744
New +$90.1K
CDRO icon
1109
Codere Online
CDRO
$408M
$84.5K 0.01%
+13,097
New +$101K
JMIA
1110
Jumia Technologies
JMIA
$728M
$84K 0.01%
22,000
+6,000
+38% +$26.9K
ABOS icon
1111
Acumen Pharmaceuticals
ABOS
$173M
$83.3K 0.01%
48,414
-4,003
-8% -$9.64K
VRA icon
1112
Vera Bradley
VRA
$98.4M
$82.9K 0.01%
21,100
-5,800
-22% -$28.9K
NAGE
1113
Niagen Bioscience
NAGE
$241M
$82.1K 0.01%
+15,474
New +$84.7K
ADT icon
1114
ADT
ADT
$5.51B
$81.5K 0.01%
+11,800
New +$85.9K
ITOS
1115
DELISTED
iTeos Therapeutics
ITOS
$81.5K 0.01%
10,608
-3,269
-24% -$28.1K
HL icon
1116
Hecla Mining
HL
$11.6B
$81.3K 0.01%
16,552
-40,887
-71% -$244K
GILT icon
1117
Gilat Satellite Networks
GILT
$837M
$80.4K 0.01%
13,080
+2,908
+29% +$15.8K
ULBI icon
1118
Ultralife
ULBI
$110M
$78.7K ﹤0.01%
10,558
-3,035
-22% -$25K
GANX icon
1119
Gain Therapeutics
GANX
$75.5M
$77.4K ﹤0.01%
35,820
KEEL
1120
Keel Infrastructure Corp
KEEL
$2.08B
$76.2K ﹤0.01%
+51,156
New +$102K
UIS icon
1121
Unisys
UIS
$214M
$75.9K ﹤0.01%
+11,986
New +$83.6K
PBYI icon
1122
Puma Biotechnology
PBYI
$448M
$75.6K ﹤0.01%
+24,800
New +$72.2K
SLSR
1123
Solaris Resources
SLSR
$1.35B
$75.5K ﹤0.01%
24,328
-9,300
-28% -$25.1K
SSRM icon
1124
SSR Mining
SSRM
$6.36B
$75.1K ﹤0.01%
10,788
-6,212
-37% -$38.6K
GTE icon
1125
Gran Tierra Energy
GTE
$322M
$74.6K ﹤0.01%
+10,312
New +$67.1K

Similar funds

Prelude Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Prelude Capital Management held 1,655 positions worth $1.6B, down 3.5% from $1.65B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $90.7M in Q4 2024, closing 477 positions and reducing 390 holdings. Its most notable exit was Core Natural Resources Inc, an estimated $11.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Arcadium Lithium plc worth $4.41M.

  • Prelude Capital Management's largest Q4 2024 buy was Arcadium Lithium plc: 859,441 shares worth $4.41M.
  • Prelude Capital Management added most to Tesla in Q4 2024, an estimated $10.1M increase.
  • Prelude Capital Management's biggest Q4 2024 reduction was Reddit, cutting an estimated $9.58M.
  • Prelude Capital Management fully exited Core Natural Resources Inc in Q4 2024, selling an estimated $11.6M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.6B portfolio in Q4 2024.
  • Prelude Capital Management opened 414 new positions and closed 477 in Q4 2024.
  • Prelude Capital Management's portfolio value fell 3.5% quarter-over-quarter to $1.6B.

Based on Prelude Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.